JAM
JW Asset Management Portfolio holdings
AUM
$203M
This Quarter Return
+4.99%
1 Year Return
+14.62%
3 Year Return
+92.55%
5 Year Return
+369.07%
10 Year Return
+1,148.19%
AUM
$275M
AUM Growth
+$275M
(+5.5%)
Cap. Flow
+$4.97M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$2.56M |
| 2 |
AdvisorShares Pure US Cannabis ETF
MSOS
|
$1.66M |
| 3 |
Celsius Holdings
CELH
|
$746K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93.36% |
| 2 | Consumer Staples | 4.94% |
| 3 | Communication Services | 0.56% |
| 4 | Materials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $219M | 79.7% |
3,192,485
| – | – |
|
|
2
Celsius Holdings
CELH
$16.2B
| $13.6M | 4.94% |
91,038
+5,000
| +6% | +$746K |
|
3
Eli Lilly
LLY
$657B
| $12.7M | 4.61% |
27,000
| – | – |
|
4
Novo Nordisk
NVO
$251B
| $9.56M | 3.48% |
59,100
| – | – |
|
5
Catalyst Pharmaceutical
CPRX
$2.52B
| $7.57M | 2.76% |
563,392
| – | – |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.21M | 1.9% |
50,673
| – | – |
|
|
7
Heron Therapeutics
HRTX
$207M
| $2.56M | 0.93% |
+2,207,418
| New | +$2.56M |
|
|
8
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $1.66M | 0.6% |
+300,000
| New | +$1.66M |
|
|
FAZE
9
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $1.54M | 0.56% |
3,126,319
| – | – |
|
10
Idaho Strategic Resources
IDR
$408M
| $1.45M | 0.53% |
271,697
| – | – |
|